Erman Akkus(@Erman_Akkus) 's Twitter Profile Photo

📖 Management of sarcoma
JCO Oncology Practice

➡️Imaging
➡️Surgery (biopsy, surgical margin, incidentally found sarcoma, lymph node management, wound healing complications)
➡️Radiotherapy (sequencing, delivery, fractination, brachytherapy)
➡️Systemic therapy (neoadjuvant, adjuvant,…

📖 Management of sarcoma
@JCOOP_ASCO 

➡️Imaging
➡️Surgery (biopsy, surgical margin, incidentally found sarcoma, lymph node management, wound healing complications)
➡️Radiotherapy (sequencing, delivery, fractination, brachytherapy)
➡️Systemic therapy (neoadjuvant, adjuvant,…
account_circle
Yakup Ergün(@dr_yakupergun) 's Twitter Profile Photo

Therapy for Stage IV Non–Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights

JCO Oncology Practice OncoAlert
ascopubs.org/doi/pdf/10.120…

Therapy for Stage IV Non–Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights

@JCOOP_ASCO @OncoAlert 
ascopubs.org/doi/pdf/10.120…
account_circle
The Innovation Oncology(@InnovOncology) 's Twitter Profile Photo

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

ASCO Journal of Clinical Oncology JCO Oncology Practice Dana-Farber

doi.org/10.1200/JCO.23…

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

@ASCO @JCO_ASCO @JCOOP_ASCO  @DanaFarber #MedEd #MedX #Oncology 

doi.org/10.1200/JCO.23…
account_circle